Topic 11 of 20
GS Paper 3 Agricultural Biotechnology Regulation Genome editing (SDN-1 and SDN-2) versus transgenic GM crops in India's regulatory framework and the limits of laboratory self-reliance

Editing a Seed Is Not Enough: Why CRISPR Can End Dependence but Not the Need for Indian Field Trials

Source The Hindu, Nobel Prize, LiveLaw, PLOS One, Bayer, Broad Institute, Nature, PIB, Indian Express, Golden Rice Project, Drishti IAS, Down To Earth, The Hindu BusinessLine, SC Observer, CSIR-NIScPR, The W

Who owns a rice seed whose genes were edited in an Indian laboratory, using a tool whose foundational patents are still under dispute abroad? Nobel laureate Richard Roberts told a Delhi audience that Indians can own such work themselves. He is mostly right, but the reason he is right and the place where he stops being right, matter more than his headline claim.

Summary

At the second Emerging Science, Technology and Innovation Conclave (ESTIC) at Bharat Mandapam on 27 October 2026, Richard J. Roberts, co-winner of the 1993 Nobel Prize in Physiology or Medicine, dismissed fears that adopting GM crops would make India dependent on foreign companies.

He argued that CRISPR-based crop editing can be learnt in six to eight weeks and owned by Indian laboratories and preferred the term biotechnologically modified to genetically modified. Asked whether Golden Rice could disturb Indian farming systems, he said he was not an agriculture expert.

India permits commercial cultivation only of Bt cotton; GM mustard was cleared by a technical body but its release stalled after a split Supreme Court verdict in 2024.

WHY IT MATTERS FOR UPSC & STATE PCS

A Nobel laureate's defence of agricultural biotechnology at ESTIC 2026 has revived the debate over whether India can build crop biotechnology domestically. It also highlights the regulatory difference between transgenic crops and genome-edited crops.

Standard News

Editing a Gene Versus Importing One

Here's what's actually happening underneath the slogans. There are two very different ways to change a crop's DNA and Richard Roberts' argument works for one of them far better than the other. Transgenic modification inserts a gene from another species.

Bt cotton carries bacterial genes that produce proteins toxic to the bollworm. It is like pasting a paragraph from another book into the text. Genome editing with CRISPR-Cas9 changes the plant's own DNA. A guide RNA leads the Cas9 enzyme to a precise spot, where it cuts and the plant's repair process makes a small change.

It is closer to correcting a typo in the existing text. The analogy has limits. A small edit can still change how a plant behaves and edits can occasionally land in the wrong place. But the basic difference holds: one method brings in foreign DNA, the other does not.

Why Roberts Is Right About Ownership

India's regulators already treat these two methods differently. In March 2022, the Environment Ministry exempted SDN-1 and SDN-2 genome-edited plants, those without foreign DNA, from the strict Rules 7-11 of the Environment Protection Rules, 1989, which govern GM crops.

The Department of Biotechnology issued guidelines and in May 2025 ICAR released India's first two genome-edited rice varieties, developed for disease resistance and higher yield. That is Roberts' point in practice. Editing is cheap and quick to learn; he estimated six to eight weeks in a laboratory.

It is being done by Indian public institutions, so the fear of depending on companies like Monsanto, now part of Bayer, carries less weight here. One caveat remains: the foundational CRISPR-Cas9 patents are still disputed between US institutions, so commercial licensing questions are not fully settled.

Why Transgenic Crops Remain Stuck

Transgenic crops are a different story. Bt cotton has been India's only approved GM crop since 2002 and pink bollworm has since developed resistance to its Cry1Ac and Cry2Ab proteins. Bt brinjal has been under a moratorium since 2010.

GM mustard DMH-11, developed at Delhi University, was cleared by the GEAC in October 2022, but its release stalled; in July 2024 the Supreme Court gave a split verdict and asked the Centre to frame a national policy on GM crops.

That policy has not been finalised. Critics such as Kavitha Kuruganti of the Coalition for a GM-Free India argue that the developers' own data does not support GM mustard's yield claims.

The Gap Roberts Avoided

When asked whether Golden Rice could disrupt Indian farming systems, Roberts said he was not an agriculture expert. That gap matters. Golden Rice was engineered in 1999 to make a vitamin A precursor in the grain. In 2017, Indian researchers reported that transferring one Golden Rice event into the popular variety Swarna produced stunted, low-yielding plants unsuitable for farming, despite high provitamin A levels.

The lesson is that laboratory skill is not the same as a crop farmers can grow. Real self-reliance in agricultural biotechnology needs Indian field trials in Indian varieties, not only Indian laboratories. For the exam, the insight is that the GM debate has two tracks and India is moving forward on gene editing because it has separated that track from the regulatory deadlock over transgenic crops.

Quick Facts

Key numbers & takeaways — revise these first

  • Richard J. Roberts shared the 1993 Nobel Prize in Physiology or Medicine with Phillip Sharp for the discovery of split genes.

  • ESTIC 2026 was held at Bharat Mandapam, New Delhi, under CSIR-NIScPR.

  • In CRISPR-Cas9, a guide RNA directs the Cas9 enzyme to a chosen point in the DNA, where it cuts.

  • In March 2022, the MoEFCC exempted SDN-1 and SDN-2 genome-edited plants without foreign DNA from Rules 7-11 of the EPA Rules, 1989.

  • In May 2025, ICAR released India's first two genome-edited rice varieties.

  • Bt cotton, commercialised in 2002, is the only GM crop approved for cultivation in India.

  • In 2010, Environment Minister Jairam Ramesh imposed an indefinite moratorium on Bt brinjal.

  • The GEAC recommended environmental release of GM mustard DMH-11 on 18 October 2022.

  • In Gene Campaign v. Union of India (July 2024), the Supreme Court split on GM mustard but unanimously asked the Centre to frame a national GM crop policy.

  • Golden Rice was engineered in 1999 by Ingo Potrykus and Peter Beyer to produce a provitamin A precursor in the grain.

Beyond The Headlines
GS Paper 3 Genome editing (SDN-1 and SDN-2) versus transgenic GM crops in India's regulatory framework and the limits of laboratory self-reliance

Connect the dots for your UPSC preparation.

Standard news covers the event. Log in to read our comprehensive analysis and uncover the hidden constitutional, structural, and ethical dimensions of this topic:

1

A side-by-side breakdown of transgenic modification, SDN-1, SDN-2 and SDN-3 and which category triggers which Indian regulatory rule.

2

How unresolved CRISPR patents could still affect commercial ownership of Indian gene-edited seeds.

3

Why the Golden Rice failure in the Swarna variety is a warning for genome-edited crops too.

4

What a national GM crop policy must contain to end the deadlock the Supreme Court identified in 2024.

Included in this analysis

Deep Analysis Sharpens your Mains-level understanding.
8 Languages Read the news comfortably in your language.
PYQ Connection Direct connection with previous year Mains questions.
Expected Questions Possible upcoming questions for Prelims & Mains.
Daily Evaluation Daily Prelims test, plus category-wise Mains evaluation.
Mentor Observation Daily, topic-wise expert feedback on your tests.
Value Additions Important Case Studies and daily Vocab Word.

Join thousands of aspirants analyzing the news deeply.

Unlock Premium — Rs.699 Annually
FOUNDATION MEMBER PRICE
₹6,999 ₹699 Annually

From Year 2: only ₹399/month for Foundation Members

More from 29 Oct 2026

Short titles by category — open any story to read it fully.